AmCad BioMed Corporation (TPEX:4188)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
13.50
+0.10 (0.75%)
Apr 28, 2025, 1:30 PM CST

AmCad BioMed Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
8491,4151,4228491,0301,027
Upgrade
Market Cap Growth
-0.45%-0.45%67.51%-17.57%0.26%-19.90%
Upgrade
Enterprise Value
5891,0501,236617758726
Upgrade
Last Close Price
13.4022.3526.1215.6018.9318.88
Upgrade
PS Ratio
15.9826.6621.7913.7712.0016.06
Upgrade
PB Ratio
1.282.132.981.631.781.73
Upgrade
P/TBV Ratio
1.692.824.632.482.622.57
Upgrade
EV/Sales Ratio
11.0919.7718.9410.018.8411.35
Upgrade
EV/FCF Ratio
-10.79-----
Upgrade
Debt / Equity Ratio
0.020.020.030.020.030.01
Upgrade
Asset Turnover
0.090.090.120.110.140.09
Upgrade
Inventory Turnover
0.730.731.001.061.171.04
Upgrade
Quick Ratio
15.3715.3712.2312.2614.438.38
Upgrade
Current Ratio
16.6316.6313.3513.1515.338.85
Upgrade
Return on Equity (ROE)
-9.26%-9.26%-8.65%-9.89%-4.58%-6.98%
Upgrade
Return on Assets (ROA)
-6.69%-6.69%-6.33%-6.87%-3.61%-5.06%
Upgrade
Return on Capital (ROIC)
-6.93%-6.93%-6.60%-7.15%-3.85%-5.64%
Upgrade
Earnings Yield
-5.96%-3.57%-3.19%-6.30%-2.48%-3.45%
Upgrade
FCF Yield
-6.43%-3.85%-2.95%-4.10%-4.01%-4.90%
Upgrade
Buyback Yield / Dilution
-8.42%-8.42%-0.01%--0.09%-0.36%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.